- QinetiQ‘s adjusted pretax profit for the first half was £111.0 million, exceeding the estimate of £109.3 million.
- Company revenue reached £946.8 million, above the projected £937.7 million.
- Adjusted operating profit stood at £119.2 million, surpassing expectations of £107.7 million.
- The interim dividend per share was declared at 2.8p, matching the forecasted figure.
- QinetiQ maintains its guidance for FY25 and aims for around £2.4 billion organic revenue at a 12% margin by FY27.
- The company has increased its share buyback programme by £50 million, bringing the total to £150 million, to enhance shareholder returns.
- Market analysts have issued 9 buy recommendations, 2 holds, and no sells for QinetiQ stock.
“`
A look at QinetiQ Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
QinetiQ Group PLC, a science and technology research company with roots in the British Government’s defense research and development organization, shows a promising long-term outlook based on its Smartkarma Smart Scores. With a Growth score of 4 and Momentum score of 5, QinetiQ indicates strong potential for future expansion and market performance. Additionally, the company ranks moderately well in terms of Value and Resilience, with scores of 2 and 3 respectively, implying stability and reasonable valuation.
While the Dividend score of 2 suggests room for improvement in terms of dividend payouts to investors, overall, QinetiQ appears well-positioned for sustained growth and market success in the coming years. Their consistent focus on innovation and technological advancements within the defense sector aligns with their solid performance indicators, making them an intriguing prospect for investors seeking long-term opportunities in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
